Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000569477

Apexbio Technology LLC RIBOCICLIB-SUCCINATE-25MG
SDP

Catalog No. 5000569477
Encompass_Preferred

Ribociclib succinate (CAS No 1374639-75-4) is a small-molecule inhibitor primarily utilized in cancer research specifically targeting cyclin-dependent kinase 4 and 6 (CDK4/6) which are critical for cell cycle progression By inhibiting these kinases Ribociclib succinate effectively arrests the cell cycle in the G1 phase thereby preventing proliferation of cancer cells It is derived from chemical synthesis processes designed for high specificity and potency In vitro studies have demonstrated its activity in the nanomolar range showcasing its efficacy in inhibiting tumor growth The compound is frequently employed in various cell line studies particularly in breast cancer models and is instrumental in preclinical animal studies to explore therapeutic effects and toxicology Ribociclib succinate is also a valuable tool in drug screening assays aimed at identifying potential combinatory treatments Experimental concentrations typically depend on the specific research design

Catalog No. 50-005-69477 Supplier Apexbio Technology LLC Supplier No. B108425
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Ribociclib succinate (CAS No 1374639-75-4) is a small-molecule inhibitor primarily utilized in cancer research specifically targeting cyclin-dependent kinase 4 and 6 (CDK4/6) which are critical for cell cycle progression By inhibiting these kinases Ribociclib succinate effectively arrests the cell cycle in the G1 phase thereby preventing proliferation of cancer cells It is derived from chemical synthesis processes designed for high specificity and potency In vitro studies have demonstrated its activity in the nanomolar range showcasing its efficacy in inhibiting tumor growth The compound is frequently employed in various cell line studies particularly in breast cancer models and is instrumental in preclinical animal studies to explore therapeutic effects and toxicology Ribociclib succinate is also a valuable tool in drug screening assays aimed at identifying potential combinatory treatments Experimental concentrations typically depend on the specific research design

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.